UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of 344.35 million as of January 23, 2025. Its market cap has increased by 2.90% in one year.

Market Cap

344.35M

Enterprise Value

237.60M

Revenue

66.67M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.06

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 344.35M, an increase of 165.49%. That is a compound annual growth rate of 13.47%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	344.35M	-4.08%
Dec 31, 2024	358.99M	-1.24%
Dec 29, 2023	363.49M	113.84%
Dec 30, 2022	169.98M	7.95%
Dec 31, 2021	157.47M	-46.00%
Dec 31, 2020	291.60M	-44.84%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shell	168.73B
AstraZeneca	167.37B
HSBC Holdings	145.28B
Unilever	113.90B
Rio Tinto Group	86.42B
RELX PLC	73.51B
BP p.l.c.	67.77B
British American Tobacco p.l.c.	65.16B

Market Cap Rankings